Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Tobacco-Related Carcinoma: early-phase trial registry
8 of 11 indexed Tobacco-Related Carcinoma trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,577 of 28,707 conditions by registered trial count.
11 US clinical trials · 8 currently recruiting · #1,577 of 28,707 conditions by registered trial count
Tobacco-Related Carcinoma: 11 US clinical trials tracked, 8 recruiting.
Tobacco-Related Carcinoma is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Ohio State University Comprehensive Cancer Center, running 6 of these trials.
Enrollment posture brief
Registry condition tobacco-related-carcinoma
OPEN 8 | RECR 73% | LATE 0 | EARLY 1 | RANK #1577 | SPON 6
Volume-matched condition peers
Nearest open-share peer: Adult (73% recruiting · 11 trials)
Tobacco-Related Carcinoma lists 8 open slots (73% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Tobacco-Related Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Tobacco-Related Carcinoma is recruiting above its size-band peers.
8 of 11 indexed trials (72.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Tobacco-Related Carcinoma research.
Ohio State University Comprehensive Cancer Center accounts for 6 of 11 trials (54.5%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Tobacco-Related Carcinoma enrolment sits around 575 participants.
Median target enrolment is 575 among the 11 trials that report a genuine target (sentinel values excluded). 1 of those (9.1%) plan for fewer than 100 participants.
-
Tobacco-Related Carcinoma research is mostly interventional.
11 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
11 total, page 1 of 1
Studying the Health Perceptions and Social Behaviors of Graduate Students at the Ohio State University for the Development of Effective Oral Nicotine Pouch Addictive Risk Communication
Ohio State University Comprehensive Cancer Center
NCT07346092
Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
Ronald Myers
NCT05679349
Healthy Family Project: Tobacco Use and Smoke Exposure in Asian American Communities
University of California, San Francisco
NCT07049757
A Smoke-Free Home Intervention in Tribal Communities
Emory University
NCT06583148
Manipulating E-Cigarette Nicotine to Promote Public Health
Ohio State University Comprehensive Cancer Center
NCT06448351
Informing Oral Nicotine Pouch Regulations to Promote Public Health
Ohio State University Comprehensive Cancer Center
NCT06315881
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
AIDS Malignancy Consortium
NCT04949464
Effects of Tobacco Cut and Nicotine Form on the Abuse Liability of Moist Snuff
Ohio State University Comprehensive Cancer Center
NCT06249984
Electronic Quitline Referral With Enhanced Academic Detailing for the Promotion of Smoking Cessation
OHSU Knight Cancer Institute
NCT04969978
Effectiveness of a Multi-Level Smoking Cessation Program for High-Risk Women in Rural Communities
Ohio State University Comprehensive Cancer Center
NCT04340531
Nicotine and Tobacco Message Framing to Change Smoking Behavior in Diverse Groups of Young Adult Smokers
Ohio State University Comprehensive Cancer Center
NCT06644664
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Tobacco-Related Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Tobacco-Related Carcinoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Tobacco-Related Carcinoma page
11 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 8 Tobacco-Related Carcinoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Ohio State University Comprehensive Cancer Center sponsors the most Tobacco-Related Carcinoma trials on record, review their full trial history before evaluating a specific study. See Ohio State University Comprehensive Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Tobacco-Related Carcinoma condition card totals 11 registered trials; most-linked intervention Survey Administration; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.